Literature DB >> 31356286

Parkinson Disease.

Theresa A Zesiewicz.   

Abstract

PURPOSE OF REVIEW: Parkinson disease is a common neurodegenerative disorder that affects millions of people worldwide. Important advances in the treatment, etiology, and the pathogenesis of Parkinson disease have been made in the past 50 years. This article provides a review of the current understanding of Parkinson disease, including the epidemiology, phenomenology, and treatment options of the disease. RECENT
FINDINGS: Parkinson disease is now recognized to be a heterogeneous condition marked by both motor and nonmotor symptoms. It is composed of preclinical, prodromal, and clinical phases. New medications with improved ease of administration have been approved for its treatment. Innovative surgical therapies for Parkinson disease may be used when motor symptoms persist despite optimal medical management.
SUMMARY: Parkinson disease is a complex, heterogeneous neurodegenerative disorder. Considerable progress has been made in its treatment modalities, both pharmacologic and surgical. While its cure remains elusive, exciting new research advances are on the horizon.

Entities:  

Year:  2019        PMID: 31356286     DOI: 10.1212/CON.0000000000000764

Source DB:  PubMed          Journal:  Continuum (Minneap Minn)        ISSN: 1080-2371


  8 in total

Review 1.  Neuropsychiatric Symptoms in Clinically Defined Parkinson's Disease: An Updated Review of Literature.

Authors:  Paloma Macías-García; Raúl Rashid-López; Álvaro J Cruz-Gómez; Elena Lozano-Soto; Florencia Sanmartino; Raúl Espinosa-Rosso; Javier J González-Rosa
Journal:  Behav Neurol       Date:  2022-05-09       Impact factor: 3.112

2.  Effect of cerebral small vessel disease on cognitive impairment in Parkinson's disease: a systematic review and meta-analysis.

Authors:  Huijuan Wan; Guangyao Wang; Qi Liu; Yilong Wang
Journal:  Ann Transl Med       Date:  2022-03

Review 3.  Natural Cinnamaldehyde and Its Derivatives Ameliorate Neuroinflammatory Pathways in Neurodegenerative Diseases.

Authors:  Mehrdad Hajinejad; Maryam Ghaddaripouri; Maryam Dabzadeh; Fatemeh Forouzanfar; Sajad Sahab-Negah
Journal:  Biomed Res Int       Date:  2020-11-14       Impact factor: 3.411

4.  Differences in MTHFR and LRRK2 variant's association with sporadic Parkinson's disease in Mexican Mestizos correlated to Native American ancestry.

Authors:  Elizabeth Romero-Gutiérrez; Paola Vázquez-Cárdenas; Hortensia Moreno-Macías; José Salas-Pacheco; Teresa Tusié-Luna; Oscar Arias-Carrión
Journal:  NPJ Parkinsons Dis       Date:  2021-02-11

5.  The Anti-Inflammatory Effect of Preventive Intervention with Ketogenic Diet Mediated by the Histone Acetylation of mGluR5 Promotor Region in Rat Parkinson's Disease Model: A Dual-Tracer PET Study.

Authors:  Yuankai Zhu; Xiangyu Tang; Zhaoting Cheng; Qingjian Dong; Ge Ruan
Journal:  Parkinsons Dis       Date:  2022-09-05

6.  Development of Parkinsonism in a Patient with Central Pontine Myelinolysis.

Authors:  Annibale Antonioni; Vittorio Rispoli; Patrik Fazio; Nico Golfrè Andreasi; Vittorio Govoni; Enrico Granieri
Journal:  Neurol Int       Date:  2022-08-25

Review 7.  Mechanistic Insights Expatiating the Redox-Active-Metal-Mediated Neuronal Degeneration in Parkinson's Disease.

Authors:  Tapan Behl; Piyush Madaan; Aayush Sehgal; Sukhbir Singh; Md Khalid Anwer; Hafiz A Makeen; Mohammed Albratty; Syam Mohan; Simona Bungau
Journal:  Int J Mol Sci       Date:  2022-01-08       Impact factor: 5.923

8.  Naturalistic Study of Depression Associated with Parkinson's Disease in a National Public Neurological Referral Center in Mexico.

Authors:  Reinhard Janssen-Aguilar; Patricia Rojas; Elizabeth Ruiz-Sánchez; Mayela Rodriguez-Violante; Yessica M Alcántara-Flores; Daniel Crail-Meléndez; Amin Cervantes-Arriaga; Óscar Sánchez-Escandón; Ángel A Ruiz-Chow
Journal:  Brain Sci       Date:  2022-02-28
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.